Search
-
NewPeaches Biotech, Universidad Autónoma of Madrid and its Foundation create the first Univer...
The UAM-Peaches Chair will promote research and teaching in the areas of Cellular Therapy and Regenerative Medicine One of the priority objectives is the search for alternatives to cell therapies
-
NewORYZON announces First Patient In in FRIDA, a Phase Ib trial with iadademstat in relapsed/...
Primary objectives: to assess safety, tolerability and RP2D
-
New#NewMember | "AseBio is the Ágora from which to connect with other people and companies in...
Meet Genios y Talentos, our new member. We talked to Egoitz Calvo Gracia, Project Coordinator of the company.
-
NewORYZON announces clinical candidate nomination of ORY-4001 for the treatment of CNS disord...
Rescues motor-neuronal deficiencies in a Charcot-Marie-Tooth model
-
NewBIOLAN HEALTH receives the start-up Medtech 2022 Tecnalia Award
The first edition of the Medtech 2022 Tecnalia awards was held on 14 February in Donostia
-
NewCEISA collaborates with the MELiSSA Pilot Plant, an external laboratory of the European Sp...
The project aims to develop a life support system for long duration manned human missions
-
NewAseBio presents first study on female participation in biotechnology industry
The event was attended by Teresa Riesgo, Secretary General for Innovation, and Ana Polanco, President of the association. The analysis highlights that 60% of the people working in companies in the
-
NewAptaTargets receives PRIME designation from the European Medicines Agency for ApTOLL in is...
AptaTargets has obtained priority medicines (PRIME) designation from the European Medicines Agency (EMA) for the neuroprotectant ApTOLL to improve the treatment of acute ischemic stroke, which
-
NewBiolan receives the Award for “Best Start-Up trajectory” at the On Bizkaia 2023 Awards
The Lifetime Achievement award is given to a startup and a spinoff that have been supported by the regional programme for the Creation of new companies, monitored by Beaz over the last five years.
-
NewAlmirall opens the doors of its R&D centre to the biotech ZeClinics
Their incorporation into Almirall's R&D facilities is the first step in Almirall's plans to create a highly collaborative environment for researchers from biotech, start-ups, academia, as well as
-
NewOur chairwoman, Ana Polanco, receives National Biotechnology Award
ISDE has recognised Polanco for her contribution to transforming the growth model through the biotechnology industry
-
NewBarcelona Science Park refinances the €36.7 M debt with the Ministry of Science and Innova...
Barcelona Science Park (PCB) has refinanced the €36.7 M debt due with the Ministry of Science and Innovation over 25 years thanks to the support of the Government of Catalonia and the University of
-
NewMikrobiomik receives the "Novel Company" award, granted by El Correo and Banco Sabadell
El lunes 20 de febrero, la compañía fue galardonada con el premio “Empresa Novel”, dentro de la entrega Premios Euskadi Avanza, y organizados por el periódico local de mayor importancia El Correo y el
-
NewORYZON Hosting Key Opinion Leader Webinar on Targeting Lysine Specific Demethylase 1 (LSD1...
Oryzon Genomics, announced today that it will host a virtual panel discussion, featuring Dr. Dyanna Phillips Domilici (Adams Clinical & Copley Clinical), Dr. med. Peter Hahn (Investigator & Neurology
-
New#NewMember | "A leading organization in terms of innovation which promotes collaboration a...
Meet CEISA, our new member. We talked to Josep Tascón, CEO of the company.
-
NewBCN HEALTH publishes a study reviewing economic evaluations and burden of disease studies ...
BCN HEALTH ha publicado el estudio 'Economic implications of endometriosis: A review' en la revista 'PharmacoEconomics'
-
NewCash, cash equivalents and marketable securities totaled $22.7 million as of December 31, ...
Strong clinical progress in both oncology and CNS
-
NewAseBio showcases strategic capacity of Spanish biotechnology industry at Transfiere
The forum is held in Malaga with over 3,000 professionals from the science and innovation sector. AseBio is displaying innovative bioproducts from over a dozen member companies that are tackling the
-
NewTelum Therapeutics names Vincent A. Fischetti chairman of its Scientific Advisory Board
Professor Vincent A. Fischetti is the inventor of phage lysins as a new therapeutic and an alternative to conventional antibiotics
-
NewAsabys announces the first close of its fund, with commitments of €100M, and appoints Sylv...
Banco Sabadell stands as the firm’s main private institutional investor, like in its previous fund in 2018. Other Investors include the European Investment Fund and Alantra
-
New#11F: AseBio launches first programme to pair female professionals and students in Spanish...
For International Day of Women and Girls in Science, 14 women from 12 companies will host young female students to encourage them to go into science and innovation and show them the different